¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (1ÀÏÂ÷) : 2023-04-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (1ÀÏÂ÷) : 2023-04-27
±³À°ÀÏÀÚ : 2023-04-27
±³À°Àå¼Ò : ¿öÄ¿Èú È£ÅÚ ¼­¿ï (ÁöÇÏ2Ãþ, ÁöÇÏ1Ãþ, 1Ãþ, 4Ãþ)

±³À°ÁÖÁ¦ : ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : À̽ÿÂ
¿¬¶ôó : 02-3452-7291  

À̸ÞÀÏ : gbcc@intercom.co.kr

±³À°Á¾·ù : ¿Ü°ú, ¼ºÇü¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, ÀÇ·á°æ¿µ

Âü¼®¿¹»óÀÎ : 1700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 98 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 800,000¿ø  

ºñ°í [Á¶±âµî·Ï(2022.11.01-2023.02.02)]Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSȸ¿ø) 400,000 Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSºñȸ¿ø) 500,000Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±ºÀÇ°ü/Çлý 150,000 [»çÀüµî·Ï(2023.02.03-2023.04.05)]Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSȸ¿ø) 480,000 Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSºñȸ¿ø) 600,000Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±ºÀÇ°ü/Çлý 200,000 [ÇöÀåµî·Ï(2023.04.27-2023.04.29)]Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSȸ¿ø) 640,000 Àü¹®ÀÇ/±³¼ö/ȸ»ç(KBCSºñȸ¿ø) 800,000Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±ºÀÇ°ü/Çлý 250,000 *http://gbcc.kr/Contents.asp?LoadPage=Instruction&Tap=B

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 27ÀÏ Vista 1+2 08:45~09:00 Opening Ceremony ( )

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 09:00~10:15 [Symposium 1: Recent Strategies for ER+/HER2- Breast Cancer] Optimal Duration of Endocrine Therapy Polly Suk Yee Cheung(Hong Kong Sanatorium and Hospital, Hong Kong)

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 09:00~10:15 [Symposium 1: Recent Strategies for ER+/HER2- Breast Cancer] The Role of CDK4/6 Inhibitors in ER+/HER2- Early Breast Cancer Tadahiko Shien(Okayama Univ. Hospital, Japan)

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 09:00~10:15 [Symposium 1: Recent Strategies for ER+/HER2- Breast Cancer] ER+/HER2 Negative Premenopausal Breast Cancer- The Biomarker Way Forward Peter C. Dubsky(Hirslanden Klinik St. Anna, Switzerland)

Åä·Ð 04¿ù 27ÀÏ Vista 3 09:00~10:15 [Panel Discussion 1: How to Manage Old-aged Breast Cancer Patients?] Screening and Assessment of Breast Cancer in Older Women Lester Leong(Singapore General Hospital, Singapore)

Åä·Ð 04¿ù 27ÀÏ Vista 3 09:00~10:15 [Panel Discussion 1: How to Manage Old-aged Breast Cancer Patients?] Systemic Therapy for Older Breast Cancer Patients Jee Hyun Kim(Seoul National Univ. Bundang Hospital, Korea)

Åä·Ð 04¿ù 27ÀÏ Vista 3 09:00~10:15 [Panel Discussion 1: How to Manage Old-aged Breast Cancer Patients?] Surgical Therapy for Older Breast Cancer Patient Tristen Park(Yale School of Medicine, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 09:00~10:15 [Education Session 1: Radiologist¡¯s Perspectives on Neoadjuvant Systemic Therapy in Breast Cancer] Causes of Over- and Underestimation of Tumor and Axillary LN After Neoadjuvant System Therapy Beatriu Reig(NYU Langone Health, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 09:00~10:15 [Education Session 1: Radiologist¡¯s Perspectives on Neoadjuvant Systemic Therapy in Breast Cancer] Evaluation of Response to Neoadjuvant Systemic Therapy: Multiparametric Approach for Accurate Evaluation of Residual Tumor Masako Kataoka(Kyoto Univ., Japan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 09:00~10:15 [Education Session 1: Radiologist¡¯s Perspectives on Neoadjuvant Systemic Therapy in Breast Cancer] How to Manage Residual Microcalcifications After Neoadjuvant Chemotherapy Sung Hun Kim(The Catholic Univ. of Korea, Seoul St. Mary)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] BREAST CANCER IN ADOLESCENT & YOUNG ADULT (AYA) AGE GROUP HAS A SPECIFIC BIOLOGICAL FEATURE AND POOR OUTCOME COMPARED TO OTHER GENERATIONS Masanori Oshi(Yokohama City University Graduate School of Medicine, Japan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] CONSECUTIVE GAIN AND LOSS IN BODY WEIGHT AND WAIST CIRCUMFERENCE WITH RISK OF SUBSEQUENT BREAST CANCER IN KOREAN WOMEN Thi Xuan Mai Tran(Hanyang Univ. College of Medicine, Vietnam)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] THE BURDEN OF BREAST CANCER IN YOGYAKARTA SPECIAL REGION, INDONESIA FROM 2008-2019: A TEMPORAL TREND ANALYSIS OF THE POPULATION-BASED CANCER REGISTRY DATA Herindita Puspitaningtyas(Faculty Of Medicine, Public Health And Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] AUGMENTING BREAST CANCER SCREENING EFFICIENCY BY MAXIMIZING DETECTION OF NORMAL MAMMOGRAMS USING AN ARTIFICIAL INTELLIGENCE ALGORITHM Serene Si Ning Goh(National Univ. of Singapore, Singapore)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] THE EFFECT OF MAMMOGRAPHIC BREAST DENSITY ON DIAGNOSTIC OUTCOMES IN MEN Hwan Lee(Univ. of Pennsylvania, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] DRUG-RESISTANT EXTRACELLULAR VESICLES PREDICT TUMOR RESPONSE IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY Jee Ye Kim(Yonsei Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] DEEP LEARNING-BASED QUANTITATIVE ESTIMATION OF LYMPHEDEMA-INDUCED FIBROSIS USING THREE-DIMENSIONAL COMPUTED TOMOGRAPHY IMAGES Chang Ho Hwang(Chungnam National Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] PROGNOSTIC VALUE OF THE NGS-BASED MULTIGENE ASSAY TO PREDICT DISTANT METASTASIS IN HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER: ANALYSIS OF THE DEVELOPMENT COHORT WITH A FOLLOW-UP OF 95 MON Eunhye Kang(Seoul National Univ. Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 09:00~10:15 [Oral Presentation 1] FEASIBILITY AND HEALTH OUTCOMES OF HOME-BASED AEROBIC AND RESISTANCE TRAINING IN INDONESIAN BREAST CANCER PATIENTS Yufi Kartika Astari(Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 09:00~10:15 [GBCC-SSO Joint Session: Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists] Management of Hereditary Breast Cancer in the U.S. Tolga Ozmen(Massachusetts General Hospital, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 09:00~10:15 [GBCC-SSO Joint Session: Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists] Management of Hereditary Breast Cancer in Europe Isabel T. Rubio(Clinica Universidad de Navarra, Spain)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 09:00~10:15 [GBCC-SSO Joint Session: Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists] Management of Hereditary Breast Cancer in Asia Sung-Won Kim(Daerim St. Mary)

ÈÞ½Ä 04¿ù 27ÀÏ 10:15~10:30 Break ( )

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 10:30~11:45 [Symposium 2: HER2-Low as a Targetable Subset of Breast Cancer] Is HER2-Low Breast Cancer an Independent/Distinctive Subtype? Naoto Ueno(Univ. of Hawai)

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 10:30~11:45 [Symposium 2: HER2-Low as a Targetable Subset of Breast Cancer] How to Identify HER2-Low Breast Cancer Hee Jin Lee(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 10:30~11:45 [Symposium 2: HER2-Low as a Targetable Subset of Breast Cancer] Targeting HER2-Low and the Treatment Sequence Wei-Pang Chung(National Cheng Kung Univ. Hospital, Taiwan)

Åä·Ð 04¿ù 27ÀÏ Vista 3 10:30~11:45 [Panel Discussion 2: Various Considerations in Premenopausal Breast Cancer Patients] The Optimal Endocrine Combination with OFS Hee Jeong Kim(ASAN Medical Center, Korea)

Åä·Ð 04¿ù 27ÀÏ Vista 3 10:30~11:45 [Panel Discussion 2: Various Considerations in Premenopausal Breast Cancer Patients] Targeted Therapy for High-risk Patients and gBRCA Mutation Patients Hee Kyung Ahn(Gachon Univ. Gil Medical Center, Korea)

Åä·Ð 04¿ù 27ÀÏ Vista 3 10:30~11:45 [Panel Discussion 2: Various Considerations in Premenopausal Breast Cancer Patients] Prophylactic Mastectomy Eric Schneider(Yale School of Medicine, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Education Session 2: Genomic Assays and Treatment Decision] Optimal Decisions on Adjuvant Endocrine and Chemotherapy Using Multigene Assays Chi-Cheng Huang(Taipei Veterans General Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Education Session 2: Genomic Assays and Treatment Decision] Clinical Parameters as Alternatives to Genomic Assays Jong Won Lee(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Education Session 2: Genomic Assays and Treatment Decision] Interpretation of Genomic Assays in Premenopausal Women Kevin Kalinsky(Winship Cancer Institute of Emory Univ., U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] GENOMIC CHARACTERIZATION OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER WITH HIGH TUMOR MUTATIONAL BURDEN: FRESH-FROZEN TISSUE GENOMIC ANALYSIS FROM MUTATION-1 STUDY (KCSG BR17-04) Min Hwan Kim(Yonsei Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] BROWN ADIPOCYTE FACILITATES BREAST CANCER INVASIVENESS VIA CELL FUSION Shihang Hu(The Univ. of Hong Kong, Hong Kong)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] COMBINATION OF LOCAL RADIOTHERAPY AND ANTI-GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) THERAPY AUGMENTS PD-L1 BLOCKADE-MEDIATED ANTI-TUMOR EFFECTS IN MURINE BREAST CANCER MODEL Jun Yeong Song(Seoul National Univ. Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] COMPARISON OF TRANSCRIPTOME PROFILES BETWEEN HER2-LOW AND HER2-ZERO BREAST CANCER Po-Hsiang Huang(National Taiwan University Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] GERMLINE MUTATIONS RELATED TO COMPLETE REMISSION AFTER NEOADJUVANT THERAPY DETECTED BY MULTIGENE PANELS IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER Jee Hyun Ahn(Yonsei Univ. College of Medicine, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] EXPLORATION OF MELK AS A DOWNSTREAM OF DEL-1 & DRUGGABLE TARGET IN TNBC In Hee Lee(Kyungpook National Univ. Chilgok Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] SYMPTOM CLUSTER AND PREDICTORS OF GENERAL CHEMOTHERAPY TOXICITY IN PATIENTS WITH BREAST CANCER: EXPLORATORY FACTOR ANALYSIS (EFA) AND A CHI-SQUARE AUTOMATIC INTERACTION DETECTOR (CHAID) DECISION TREE Juan Adrian Wiranata(Master Of Clinical Epidemiology Postgraduate Program, Indonesia)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] B-CELL MEDIATED IMMUNITY PREDICTS SURVIVAL OF ER-POSITIVE BREAST CANCER Byung-Hee Kang(Seoul National Univ. Bundang Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 10:30~11:45 [Oral Presentation 2] IMPROVEMENT OF DIAGNOSTIC ACCURACY OF BREAST CANCER USING MULTI-PROTEIN SIGNATURE MARKERS THROUGH MACHINE LEARNING Yumi Kim(CHA Gangnam Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 10:30~11:45 [GBCC-JBCS Joint Session: Holistic Management for Breast Cancer Patients in Pandemic Era] Present and Future Perspectives in Korea So-Youn Jung(National Cancer Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 10:30~11:45 [GBCC-JBCS Joint Session: Holistic Management for Breast Cancer Patients in Pandemic Era] Present and Future Perspectives in Japan Akihiko Shimomura(National Center for Global Health and Medicine, Japan)

ÈÞ½Ä 04¿ù 27ÀÏ 11:45~12:00 Break ( )

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 12:00~12:45 [Plenary Lecture 1] A Revolution in the Making: How Antibody-Drug Conjugates are Transforming Breast Cancer Treatment Ian Krop(Yale School of Medicine, U.S.A.)

ÈÞ½Ä 04¿ù 27ÀÏ 12:45~13:00 Break ( )

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 13:00~13:45 [Satellite Symposium 1] Pembrolizumab for More TOMORROWs in TNBC Yen-Shen Lu(National Taiwan Univ. Hospital, Taiwan)

ÈÞ½Ä 04¿ù 27ÀÏ 13:45~14:00 Break ( )

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 1+2 14:00~14:45 [Plenary Lecture 2] Fertility Issues in Young Breast Cancer Patients Sibylle Loibl(GBG Forschungs GmbH, Germany)

ÈÞ½Ä 04¿ù 27ÀÏ 14:45~15:00 Break ( )

Åä·Ð 04¿ù 27ÀÏ Vista 3 15:00~16:15 [Panel Discussion 3: Optimal Surgical Treatment After Neoadjuvant Chemotherapy] Avoiding Breast Surgery in Patients with Radiologic Complete Response Christoph Tausch(Breast-Center Zurich, Switzerland)

Åä·Ð 04¿ù 27ÀÏ Vista 3 15:00~16:15 [Panel Discussion 3: Optimal Surgical Treatment After Neoadjuvant Chemotherapy] De-escalation of Sentinel Lymph Node Biopsy in Patients with Radiologic Complete Response Shih-Che Shen(Chang Gung Memorial Hospital, Taiwan)

Åä·Ð 04¿ù 27ÀÏ Vista 3 15:00~16:15 [Panel Discussion 3: Optimal Surgical Treatment After Neoadjuvant Chemotherapy] De-escalation of Radiotherapy in Patients Achieved Pathologically Complete Response Yeon-Joo Kim(National Cancer Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 15:00~16:15 [Symposium 3: Beyond CDK4/6 Inhibitor: New Target and New Drugs] Novel Oral SERD and its Implication in Clinical Practice Yen-Shen Lu(National Taiwan Univ. Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 15:00~16:15 [Symposium 3: Beyond CDK4/6 Inhibitor: New Target and New Drugs] Treatment Strategy After Progression on CDK4/6 Inhibitor Nadia Harbeck(LMU Univ. Hospital, Germany)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 15:00~16:15 [Symposium 3: Beyond CDK4/6 Inhibitor: New Target and New Drugs] New Targets Beyond CDK4/6 Inhibitor: Development in Progress Yong Wha Moon(CHA Bundang Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] IMPACT OF RESIDUAL MICROCALCIFCATIONS ON PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS Eun Young Kim(Kangbuk Samsung Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] IS AGE AN INDEPENDENT FACTOR OF LATE RECURRENCE AMONG YOUNG BREAST CANCER PATIENTS WITH ESTROGEN RECEPTOR POSITIVE/HER2 NEGATIVE? Dong Seung Shin(Samsung Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] STROMAL TUMOR INFILTRATING LYMPHOCYTES (TIL) AS A POTENTIAL PROGNOSTIC BIOMARKER FOR RECURRENCE IN LOCALLY ADVANCED BREAST CANCER (LABC) PATIENTS Dannu Novriandhika(Medical Faculty Airlangga University, Dr Soetomo General Hospital Surabaya, Indonesia)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] DEVELOPMENT OF BREAST CANCER RISK PREDICTION MODEL INCORPORATING POLYGENIC RISK SCORE AND NONGENETIC RISK FACTORS IN KOREAN WOMEN Jihye Choi(National Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] LONG-TERM PROGNOSTIC VALUE OF THE GENESWELL BCT SCORE IN ASIAN WOMEN WITH HORMONE RECEPTOR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER Youngwon Lee(ASAN Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] ESTABLISHING THE CORRELATION OF AN 8-GENE SET OF IMMUNE-RESPONSE GENE EXPRESSION PROFILING WITH PATHOLOGICAL COMPLETE RESPONSE NEOADJUVANT CHEMOTHERAPY IN PRIMARY BREAST CANCER PATIENTS Chun-Yu Liu(Taipei Veterans General Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] MIR-606 INHIBITS THE GROWTH AND METASTASIS OF TRIPLE-NEGATIVE BREAST CANCER BY TARGETING STANNIOCALCIN 1 Isaac Kim(CHA Bundang Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] THE EFFECT OF PROGESTERONE RECEPTOR EXPRESSION LEVEL TO PREDICT PROGNOSIS OF ESTROGEN RECEPTOR POSITIVE/ HER2 NEGATIVE YOUNG BREAST CANCER: A SINGLE-CENTER PROSPECTIVE COHORT STUDY. Youngji Kwak(Samsung Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 15:00~16:15 [Oral Presentation 3] ELUCIDATING THE MUTATIONAL LANDSCAPE OF PI3K PATHWAY AMONG INDIAN BREAST CANCER CASES. Rahul Kumar(All India Institute of Medical Sciences, New Delhi, India)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 15:00~16:15 [GBCC-TBCS Joint Session: Making Evidences Together] Breast Cancer Registry from the Korean Breast Cancer Society Jaihong Han(National Cancer Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 15:00~16:15 [GBCC-TBCS Joint Session: Making Evidences Together] Nationwide Taiwanese Breast Cancer Study Ching-Hung Lin(National Taiwan Univ. Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 15:00~16:15 [GBCC-TBCS Joint Session: Making Evidences Together] Korean Breast Cancer Study Using National Insurance Big Data Sungmin Park(Chungbuk National Univ. Hospital, Korea)

ÈÞ½Ä 04¿ù 27ÀÏ 16:15~16:30 Break ( )

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 3 16:30~17:45 [Education Session 3: Special Issues in Young Women with Breast Cancer Treated with Radiotherapy] Breast Radiotherapy During Pregnancy Stefanie Corradini(Univ. Hospital, LMU Munich, Germany)

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 3 16:30~17:45 [Education Session 3: Special Issues in Young Women with Breast Cancer Treated with Radiotherapy] Risk of Contralateral Breast Cancer After Breast Radiotherapy in Young Women Seung Won Seol(Univ. of Pennsylvania, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Vista 3 16:30~17:45 [Education Session 3: Special Issues in Young Women with Breast Cancer Treated with Radiotherapy] Heart Disease After Breast Radiotherapy in Young Women Ji Hyeon Joo(Pusan National Univ. Yangsan Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 16:30~17:45 [Symposium 4: Tailored Surgery in Early-stage Breast Cancer] Individualized Surgical Extent and Lumpectomy Margin in Early-stage Breast Cancer: Does Tumor Histology and Subtype Matter? Naoki Hayashi(Showa Univ. School of Medicine, Japan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 16:30~17:45 [Symposium 4: Tailored Surgery in Early-stage Breast Cancer] The Role of Axillary Surgery for DCIS and Early-stage Breast Cancer Wonshik Han(Seoul National Univ. Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 1 16:30~17:45 [Symposium 4: Tailored Surgery in Early-stage Breast Cancer] Pre-operative Genomic Assay for Breast Surgery Guidance in HR+/HER2- Breast Cancer Caroline Drukker(Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Netherlands)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] NATIONAL PATTERNS OF HOSPITAL ADMISSION VS HOME RECOVERY FOLLOWING MASTECTOMY FOR BREAST CANCER Leah Kim(Yale University School of Medicine, U.S.A.)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] IMPACT OF DISTANCE BETWEEN TUMOR AND NIPPLE ON SURVIVAL OUTCOMES IN BREAST CANCER Jong-Ho Cheun(SMG-SNU Boramae Medical Center, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] THE IMPACT OF CAVITARY MARGIN SHAVING OF BREAST CONSERVING SURGERY: THE ONCOLOGICAL OUTCOME Dabin Kim(Soonchunhyang Univ. Hospital Bucheon, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] FUNCTIONALITY BETWEEN BREAST CONSERVATION SURGERY VS MASTECTOMY: SHORT TERM OUTCOME FROM A SINGLE INSTITUTION Lorraine Ma(Pamela Youde Nethersole Eastern Hospital, Hong Kong)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] POST-OPERATIVE OUTCOMES OF ROBOT-ASSISTED NIPPLE-SPARING MASTECTOMY WITH IMMEDIATE BREAST RECONSTRUCTION REGARDING TO ROBOT SURGICAL SYSTEMS Jieon Go(Severance Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] COMPARISON OF LONG-TERM ONCOLOGICAL OUTCOMES OF CENTRAL LUMPECTOMY AND CONVENTIONAL BREAST-CONSERVING SURGERY FOR INVASIVE BREAST CANCER Jijung Jung(Seoul National Univ., Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] RISK FACTOR OF SKIN AND NIPPLE-AREOLAR COMPLICATION AND ONCOLOGIC SAFETY IN DIFFERENT APPROACH NIPPLE SPARING MASTECTOMY: A LONG-TERM FOLLOW-UP IN A SINGLE MEDICAL CENTER Ruoh Yun Gau(Chang Gung Memorial Hospital, Taiwan)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] LONG-TERM ONCOLOGICAL OUTCOMES OF ONCOPLASTIC BREAST-CONSERVING SURGERY AFTER A 10-YEAR FOLLOW-UP: A SINGLE CENTER EXPERIENCE AND SYSTEMATIC LITERATURE REVIEW Byeongju Kang(Kyungpook National Univ. Chilgok Hospital, Korea)

±³À°½Ã°£ 04¿ù 27ÀÏ Walker Hall 2 16:30~17:45 [Oral Presentation 4] OCCULT LYMPH NODE METASTASES IN CLINICALLY NODE-NEGATIVE (CN0) BREAST CANCER PATIENTS REFERRED FOR NEOADJUVANT THERAPY (NAT) Si Ying Tan(Singapore General Hospital, Singapore)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 16:30~17:45 [GBCC-CACA Joint Session: Programs for Breast Cancer Screening and Prevention] KBCS Guidelines of Screening and Current Status Young-Joon Kang(The Catholic Univ. of Korea, Incheon St. Mary)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 16:30~17:45 [GBCC-CACA Joint Session: Programs for Breast Cancer Screening and Prevention] CACA Guidelines of Screening and Current Status Yongsheng Wang(Shandong Cancer Hospital & Institute, China)

±³À°½Ã°£ 04¿ù 27ÀÏ Art Hall 16:30~17:45 [GBCC-CACA Joint Session: Programs for Breast Cancer Screening and Prevention] Korean Recommendations for Prevention and Risk Managements Yoo Seok Kim(Chosun Univ. Hospital, Korea)

±âŸ 04¿ù 27ÀÏ Walker Hall 1 17:45~18:00 KBCS General Assembly ( )

½Ä»ç 04¿ù 27ÀÏ Vista 1+2 18:00~19:30 Welcome Dinner ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2023 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2023) (1ÀÏÂ÷) : 2023-04-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2023 Ãá°è½ÉÆ÷Áö¾ö(1ÀÏÂ÷) : 2023-04-27
´ÙÀ½±Û ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­¿ï µ¿ºÎÁöȸ ¿ù·ÊÁý´ãȸ : 2023-04-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 76 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 50 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 47 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 49 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 36 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 29 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷